Plain-English translation of NCT07091318 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This study is testing whether a talk-based therapy called cognitive behavioral therapy for insomnia (CBTi) can help people with type 1 diabetes sleep better and control their blood sugar levels more effectively. The therapy is customized to address the specific sleep challenges that come with managing diabetes. Researchers want to see if better sleep leads to better blood sugar control and improved quality of life.
Many people with type 1 diabetes struggle with sleep problems, which can make blood sugar harder to control and affect overall health and mood. This trial aims to find out whether treating sleep directly can help improve both sleep quality and diabetes management.
You likely qualify if…
You likely don't qualify if…
You will be in the study for 12 weeks. You'll either receive 8 virtual therapy sessions with a therapist (once per week for 4 weeks, then every other week), or you'll receive weekly health education emails and brief check-in calls from a coach. All participants will wear a sleep-tracking watch for 2 weeks, share their glucose monitor data, complete questionnaires at the start, midway, and end of the study, and attend 3 in-person office visits.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States